Stock Rating Upgrade
The Value Trend Rating for CorMedix Inc (NASDAQ: CRMD) improved in recent days from D to C reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
On 5/20/24, CorMedix Inc (NASDAQ: CRMD) stock declined modestly by -1.4%, closing at $5.05. This decline was accompanied by normal trading volume. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -2.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, CRMD is expected to continue to be Value Creation neutral.
CorMedix has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. CorMedix has a very low Appreciation Score of 3 but a very high Power Rating of 86, resulting in the Low Neutral Value Trend Rating.
Be the first to comment